What is an isocitrate dehydrogenase-mutated central nervous system World Health Organization grade 2 glioma, or who should receive vorasidenib?

Preusser, M; Geurts, M; Hainfellner, JA; van den Bent, MJ

Preusser, M (通讯作者),Med Univ Vienna, Dept Med 1, Div Oncol, Vienna, Austria.

NEURO-ONCOLOGY, 2023; 25 (11): 1915